← Leaderboards
Timothy A Haystead
University Of Virginia Charlottesville
$11,993,276
Attributed
$17,445,853
Total exposure
16
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,445,853 · 16
By mechanism
R01$8,303,744 · 4
R44$4,310,173 · 2
R21$1,484,117 · 1
P01$1,198,713 · 1
R43$1,074,950 · 2
P30$329,609 · 1
Top collaborators
- Scott Scarneo7 shared
- Daniel A Engel5 shared
- Mariano A. Garcia-Blanco5 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Barry T. Hinton$9,804,435
- Pablo Eduardo Visconti$12,268,970
- Charles David Allis$30,045,613
- William R Pearson$5,603,930
- David L. Brautigan$8,085,875
Others in their field
Top investigators on “Protein Kinase”
- David Heimbrook · Leidos Biomedical Research, Inc.$63,024,346
- Asrar B. Malik · University Of Illinois At Chicago$42,318,340
- John Blenis · Harvard University (Medical School)$31,872,790
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$25,670,024
- Michael H Nathanson · Yale University$25,355,113
- Joel S Greenberger · University Of Pittsburgh At Pittsburgh$24,937,005
Research focus
Protein KinaseBaseProteinsPhosphorylationIn VivoLeadProgramsCellsPharmaceutical PreparationsMediatingSignal TransductionResponseElementsInhibitor/AntagonistProteomicsScaffoldMouse ModelResearch PersonnelIn VitroPlayLaboratoriesHuman DiseaseAnimalsProtein Sequence
Grant awards (44)
Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease$1,417,658
R44 · FY2025 · HL
Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease$1,182,632
R44 · FY2024 · HL
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis$913,097
R44 · FY2022 · AR
Acute Inhibition of TAK1 as a Means to Control COVID-19 Pulmonary Hyperinflammation$284,707
R43 · FY2022 · HL
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis$796,786
R44 · FY2021 · AR
Evaluating the Blood-Brain Barrier Bioavailability and in vivo Efficacy Potential of a Novel TAK1 Inhibitor Targeting Chronic Pain$480,955
R43 · FY2021 · NS
Acute Inhibition of TAK1 as a Means to Control COVID-19 Pulmonary Hyperinflammation$309,288
R43 · FY2021 · HL
Improving the Oral Bioavailability and In vivo Efficacy of a Novel TAK1 Inhibitor Targeting Rheumatoid Arthritis$223,898
R41 · FY2019 · AR · contact PI
Discovery and development of broad spectrum anti-flaviviral drugs$826,847
R01 · FY2014 · AI · contact PI
Discovery and development of broad spectrum anti-flaviviral drugs$764,373
R01 · FY2013 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$835,261
R01 · FY2012 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$844,425
R01 · FY2011 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$869,118
R01 · FY2010 · AI
Calcium desensitization in Smooth Muscle.$234,000
R56 · FY2010 · DK · contact PI
Calcium desensitization in Smooth Muscle$304,314
R01 · FY2009 · DK · contact PI
PROTEOMICS FACILITY$91,484
P30 · FY2009 · CA · contact PI
Regulation of smooth muscle-myosin phosphatase 1 kinase$365,049
R01 · FY2008 · HL · contact PI
Proteome Mining as a Predicitve Tool of Drug Toxicity$358,114
R21 · FY2008 · GM · contact PI
Calcium desensitization in Smooth Muscle$304,314
R01 · FY2008 · DK · contact PI
PROTEOMICS FACILITY$62,196
P30 · FY2008 · CA · contact PI
Proteome Mining as a Predicitve Tool of Drug Toxicity$365,050
R21 · FY2007 · GM · contact PI
Regulation of smooth muscle-myosin phosphatase 1 kinase$365,049
R01 · FY2007 · HL · contact PI
Calcium desensitization in Smooth Muscle$310,277
R01 · FY2007 · DK · contact PI
PROTEOMICS FACILITY$60,385
P30 · FY2007 · CA · contact PI
Regulation of smooth muscle-myosin phosphatase 1 kinase$375,953
R01 · FY2006 · HL · contact PI
Proteome Mining as a Predicitve Tool of Drug Toxicity$375,953
R21 · FY2006 · GM · contact PI
Calcium desensitization in Smooth Muscle$318,519
R01 · FY2006 · DK · contact PI
PROTEOMICS FACILITY$58,626
P30 · FY2006 · CA · contact PI
EVALUATE BLOOD FLOW LUNG, BRAIN, HEART, KIDNEY IN WILD-TYPE MICE W/ CONTRAST$5,126
P41 · FY2006 · RR · contact PI
Proteome Mining as a Predicitve Tool of Drug Toxicity$385,000
R21 · FY2005 · GM
Regulation of smooth muscle-myosin phosphatase 1 kinase$385,000
R01 · FY2005 · HL
Protein Phosphatase 1 Regulation by Multiple Subunits$304,920
R01 · FY2005 · DK
PROTEOMICS FACILITY$56,918
P30 · FY2005 · CA
EVALUATE BLOOD FLOW IN LUNG, BRAIN, HEART, AND KIDNEY IN WILD-TYPE MICE USING I$5,331
P41 · FY2005 · RR
Protein Phosphatase 1 Regulation by Multiple Subunits$304,920
R01 · FY2004 · DK
Protein Phosphatase 1 Regulation by Multiple Subunits$304,920
R01 · FY2003 · DK
REGULATION OF SMOOTH MUSCLE CONTRACTION BY PHOSPHATASES$399,571
P01 · FY2002 · HL
Protein Phosphatase 1 Regulation by Multiple Subunits$304,920
R01 · FY2002 · DK
REGULATION OF SMOOTH MUSCLE CONTRACTION BY PHOSPHATASES$399,571
P01 · FY2001 · HL
REGULATION OF SMOOTH MUSCLE CONTRACTION BY PHOSPHATASES$399,571
P01 · FY2000 · HL
IDENTIFICATION OF MARKERS OF INSULIN RESISTANCE IN HUMAN PLATELETS$248,088
M01 · FY2000 · RR
PROTEIN PHOSPHATASE 1 REGULATION BY MULTIPLE SUBUNITS$186,254
R01 · FY2000 · DK
PROTEIN PHOSPHATASE 1 REGULATION BY MULTIPLE SUBUNITS$29,311
R01 · FY2000 · DK
IDENTIFICATION OF MARKERS OF INSULIN RESISTANCE IN HUMAN PLATELETS$28,104
M01 · FY2000 · RR